ksoulstring

About Kenny Soulstring

Kenny Soulstring is an entrepreneurial visionary with a thirty year history developing and operating small to mid sized businesses. His experience in building a brand led to his interest in investing in small and emerging companies, and for the prior twenty years, his investments allow him to take part in new ventures without undertaking all of the legwork. Focused on finding compelling opportunities in the small cap sector, Soulstring enjoys the art of the build, watching a company develop from concept to maturity. His frequent contact with company management allows him to offer timely and relevant information, working to keep news fresh with a spicy commentary to match. Soulstring was raised in Miami Beach, Florida and plans to retire there when his hair turns fully gray.
Aytu BioScience’s (AYTU) “Natesto” to Target Low Testosterone
  • Aytu BioScience’s (AYTU) “Natesto” to Target Low Testosterone

Aytu BioScience’s (AYTU) “Natesto” to Target Low Testosterone

By |February 23rd, 2017|

Aytu BioScience Inc (OTCMKTS: AYTU)

Let’s get an important disclosure out of the way quickly: I am long Aytu BioScience, and for good reason.

Now, while some may argue that this statement is merely an overzealous pitch, it isn’t. In fact, the case for AYTU being a hidden gem is just as powerful as it was in December […]

Naked Brand Group (NAKD) Stock: Being Naked…How Bendon May Build A Powerhouse Brand
  • Naked Brand Group (NAKD) Stock: Being Naked…How Bendon May Build A Powerhouse Brand

Naked Brand Group (NAKD) Stock: Being Naked…How Bendon May Build A Powerhouse Brand

By |February 22nd, 2017|

Naked Brand Group Inc (NASDAQ: NAKD)

Investors who are attracted to emerging companies are not exactly a rare breed, but, for all intents and purposes, they do share some inherent traits that make them somewhat of a renegade spirit in the investment world. Let’s face it, these investors aren’t easily phased by turbulent volatility, are willing to […]

First Choice Health Solutions (FCHS): A Revolutionary Healthcare Delivery Platform
  • First Choice Health Solutions (FCHS): A Revolutionary Healthcare Delivery Platform

First Choice Health Solutions (FCHS): A Revolutionary Healthcare Delivery Platform

By |February 14th, 2017|

First Choice Healthcare Solutions Inc (OTCMKTS: FCHS)

To those who believe the medical services industry will survive in its current state, think again. The healthcare system in the United States may not be entirely broken, but it is certainly fractured, bringing dysfunction to almost every corner of the industry, including reimbursements, drug prices and patient […]

Why Actinium Pharmaceutics (ATNM) Stock May Be Even Better Than Celator

By |February 7th, 2017|

Actinium Pharmaceuticals Inc (NYSEMKT: ATNM)
If you think that I wrote a presumptuous Actinium Pharmaceuticals headline to simply grab your attention, you are mistaken. After extensive analysis of the company, I hold a firm belief that ATNM has the potential to mimic the dramatic rise of Celator, which saw its market cap increase from roughly […]

DarioHealth (DRIO) Stock - A Disruptive Force in the Diabetes Monitoring Industry
  • DarioHealth (DRIO) Stock - A Disruptive Force in the Diabetes Monitoring Industry

DarioHealth (DRIO) Stock – A Disruptive Force in the Diabetes Monitoring Industry

By |February 1st, 2017|

DarioHealth Corp (NASDAQ: DRIO)
For investors seeking emerging growth investment opportunities, DarioHealth is worth a close look for investment selection. DarioHealth whose MyDario mobile data management platform is disrupting the multi-billion dollar diabetes monitoring industry within a unique, all-digital, patient-centric glucose monitor. Dario launched in the U.S. in March 2016 and has since ramped to […]

C-Suite: Viking Investments CEO Explains Why VKIN Stock Is Set to Move Higher
  • C-Suite: Viking Investments CEO Explains Why VKIN Stock Is Set to Move Higher

C-Suite: Viking Investments CEO Explains Why VKIN Stock Is Set to Move Higher

By |January 24th, 2017|

Viking Investments Group, Inc. (“VKIN” or “Viking”) is taking an aggressive stance to reposition itself as a premier player within the oil and gas industry, undertaking an aggressive acquisition strategy planned for 2017 and beyond. Taking advantage of strong banking relationships and an already beefed up portfolio of producing assets, Viking may very well […]

Is AzurRx (AZRX) About to Transform the Gastrointestinal Treatment Industry?
  • Is AzurRx (AZRX) About to Transform the Gastrointestinal Treatment Industry?

Is AzurRx (AZRX) About to Transform the Gastrointestinal Treatment Industry?

By |January 5th, 2017|

AzurRX BioPharma Inc (NASDAQ: AZRX)

As a goal, I strive to find emerging companies that are hidden gems in an industry: ones that are in a position to cause a paradigm shift in technology, benefiting not only investors, but also rewards recipients of that technology with a better method of treatment or service.

For AzurRx, the […]

IEG Holdings (IEGH) Stock: "Mr. Amazing Loans" Swing To Profitability
  • IEG Holdings (IEGH) Stock: "Mr. Amazing Loans" Swing To Profitability

IEG Holdings (IEGH) Stock: “Mr. Amazing Loans” Swing To Profitability

By |January 4th, 2017|

While many lenders in the quick service, on-line lending sector have seen a relative slowdown in customer acquisition rates due to the prolific rise in the competitive landscape, IEGH is proving its ability to buck that trend.
IEG Holdings, leveraging off of the strength of their “Mr. Amazing Loans” product has not only experienced tremendous […]

AzurRx BioPharma (AZRX) Stock: An Emerging Leader to Treat Gastrointestinal Disease
  • AzurRx BioPharma (AZRX) Stock: An Emerging Leader to Treat Gastrointestinal Disease

AzurRx BioPharma (AZRX) Stock: An Emerging Leader to Treat Gastrointestinal Disease

By |December 27th, 2016|

AzurRX BioPharma, Inc (NASDAQ: AZRX)

AzurRx has been generating a lot of attention lately. And, while many emerging companies tend to get some early nods from investors and analysts, the focus on AZRX has strong fundamental underpinnings.

AzurRx is developing a broad pipeline of non-systemic biologics to treat gastrointestinal (GI) and infectious diseases. Importantly, for AzurRx […]

Vitality Biopharma (VBIO): A Seriously Undervalued Cannabis Stock
  • Vitality Biopharma (VBIO): A Seriously Undervalued Cannabis Stock

Vitality Biopharma (VBIO): A Seriously Undervalued Cannabis Stock

By |December 20th, 2016|

Vitality Biopharma Inc (OTCMKTS: VBIO)

Beginning in 2014, marijuana stocks were in vogue. Investors were scrambling the markets to find almost any stock that promoted themselves as an emerging player in the cannabis industry. The drawback in that investment strategy, however, was that many investors were too preoccupied with finding a company with a catchy […]